Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will ...
Finding new ways in the approach to colorectal cancer is therefore fundamental. And there is no shortage of good news. Italy is the first country in Europe to guarantee, through the National Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results